Table 1 Patients had preexisting T cells to multiple prostate-specific proteins. Shown are the number and % of patients with IFNγ-, granzyme B- (Grz), IL-10-, or IL-6-secreting responses to one or more (or none) of the three prostate cancer-associated proteins (PAP, PSA or AR)

From: Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination